Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. (Q45338061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

29 January 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Richard Rheingans

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Deborah Atherly

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

30 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

A15-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22520124%20AND%20SRC:MED&resulttype=core&format=json

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Projected cost-effectiveness of rotavirus vaccination for children in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Measles vaccination improves the equity of health outcomes: evidence from Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Human papilloma virus vaccine--more than a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Overcoming barriers and ensuring access to HPV vaccines in low-income countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

How many lives is equity worth? A proposal for equity adjusted years of life saved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Reconciliation of Economic Concerns and Health Policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Efficiency, equity, and budgetary policies: informing decisions using mathematical programming.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Balancing Equity and Efficiency in Health Priorities in Ghana: The Use of Multicriteria Decision Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Subgroups and heterogeneity in cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Insecticide-treated net coverage in Africa: mapping progress in 2000-07

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Spatial modelling of soil-transmitted helminth infections in Kenya: a disease control planning tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Eradicating diseases: The effect of conditional cash transfers on vaccination coverage in rural Nicaragua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018

Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.018